Columbia Laboratories has a rich heritage in pharmaceutical research and development that has helped place the company on the forefront of women's healthcare and drug delivery. Our products use the principles of bioadhesion to achieve controlled, sustained delivery of hormones and other compounds that are difficult to administer. Commercially available products using our drug delivery technologies include:
Of these, the majority of our revenues are from CRINONE, for which we receive sales and royalty revenues from Actavis, Inc. and sales revenues from Merck Serono in the U.S. and rest-of-world, respectively.
STRIANT® is a registered trademark of Actient Pharmaceuticals LLC. CRINONE® ia a registered trademark of Actavis, Inc. Replens® and RepHresh® are registered trademarks of Lil' Drug Store Products, Inc.